The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.

@article{Mellbin2013TheRB,
  title={The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.},
  author={Linda Garcia Mellbin and Klas Malmberg and Lars Ryd{\'e}n and Hans Wedel and Daniel Vestberg and Marcus Lind},
  journal={European heart journal},
  year={2013},
  volume={34 5},
  pages={374-9}
}
AIMS Hyperglycaemia during hospitalization for acute myocardial infarction (AMI) is a risk predictor, but attempts to improve the prognosis by insulin-based glucose control have not been consistently successful. Increased glycaemic variability, a potential effect of insulin treatment, has been linked to a worse prognosis in critically ill patients. The present aim was to study the possibility of such a relation in patients with type 2 diabetes (T2DM) and AMI. METHOD AND RESULTS We studied 578… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 29 references

A systematic review of HbA1c variables used in the study of diabetic complications

  • M Lind, A Odén, M Fahlén, B. Eliassion
  • Diabetes Metab Syndr Clin Res Rev 2008;2:282–293
  • 2008
Highly Influential
2 Excerpts

Addressing glycaemic variation

  • J. Seufert
  • Br J Diabetes Vasc Dis 2011;11:2–5
  • 2011
1 Excerpt

in Chinese population with type 2 diabetes

  • L Monnier, E Mas, +4 authors C Colette
  • 2010

Similar Papers

Loading similar papers…